Latest News > Portfolio Company News

Cellipont bags investment from OrbiMed to complete Texas plant

BioProcessInternational’s coverage of Cellipont’s strategic debt facility investment from OrbiMed to finance its state-of-the-art commercial facility for cell therapies and gene-modified cell therapies.